Altre lingue 10x Genomics, Inc.

Azioni

TXG

US88025U1097

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 25/04/2024			Variaz. 5gg	Var. 1 gen.
26,9 ^USD	-2,25%		-7,08%	-51,93%

18/04	10X GENOMICS, INC. : Deutsche Bank Securities ancora positivo	ZM
26/03	10x Genomics, Inc. lancia commercialmente il saggio di espressione genica spaziale Visium HD	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Petition Denied For Lacking Section 112(f) Construction And Fintiv	18/04
The UPC Court Of Appeal's First Decision: What Does It Mean For The Assessment Of Inventive Step At The UPC?	17/04
UPC Court Of Appeal Overturns Preliminary Injunction In Its First Substantive Decision	15/04
10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024	10/04
UPC Court Of Appeal Reverses Preliminary Injunction In First Substantive Decision	29/03
10x Genomics Commercially Launches Visium HD Spatial Gene Expression Assay	26/03
10x Genomics, Inc. Commercially Launches Visium HD Spatial Gene Expression Assay	26/03
10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel	21/03
10X Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene Panel	21/03
Vizgen Announces Denial of 10x Genomics Petition for Inter Partes Review of Vizgen-Licensed Patent Currently Asserted against 10x's Xenium Platform	14/03
10x Genomics Launches Two New Products With Single Cell Technology	13/03
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products	13/03
10x Genomics, Inc. Begins Commercial Shipments of Chromium GEM-X Products	13/03
Element Biosciences Announces Senior Vice President of Global Sales and Support	13/03
10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference	20/02
10x Genomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/02
10x Genomics Q4 Net Loss Widens, Revenue Increases; Issues Outlook	15/02
Earnings Flash (TXG) 10X GENOMICS Reports Q4 Revenue $184M, vs. Street Est of $183.7M	15/02
10x Genomics: Q4 Earnings Snapshot	15/02
10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024	15/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue 10x Genomics, Inc.

Azioni

TXG

US88025U1097

Altre lingue

Filtri